MD Revenue Group provides specialized, high-performance revenue cycle management for independent allergy practices, multi-physician immunology groups, and specialized immunotherapy centers. We eliminate "Unit-Level Leakage" by mastering the complex 2026 shifts in immunotherapy extraction math, venom testing complexity, and the high-cost biologic authorizations (e.g., Xolair, Nucala) that now define allergy practice margins. Our Medical Billing Services are engineered to transform your high-volume allergy practice from a reactive back-office task into a proactive capital recovery engine.
Claim Free Allergy & Immunology AuditFor an independent allergist, the choice to outsource RCM isn't about giving up control—it's about gaining technical leverage against aggressive payers who want to commoditize your high-acuity diagnostics. Our Medical Billing Services provide the administrative backbone required to allow your physicians to focus on patient outcomes rather than insurance friction.
As you add new physicians, specialized immunology mid-levels, or specialized clinical educators, your Revenue Cycle Management scales instantly without the need for additional Credentialing staff or office space.
By catching technical and mathematical errors (like Payer Enrollment gaps or expired facility links) *before* submission, we dramatically accelerate your cash flow for high-volume skin testing months.
We build "Audit-Armor" into the foundation of your allergy practice. Our experts ensure that every skin-test log, every extract preparation record, and every risk-adjustment (HCC) score is "Ready for Scrutiny" before it ever leaves your office.
Allergy and immunology is a specialty defined by high procedure volume, rapid-fire clinical diagnostics, and the extreme administrative complexity of managing immunotherapy units. In 2026, the administrative friction for immune care has reached an all-time high, with payers using advanced AI-algorithms to audit "Unit-to-Dilution" logic and to challenge the "Medical Necessity" of high-cost biologic therapies.
A primary source of revenue erosion for allergy groups is the failure to perfectly calculate and document the number of units for allergy extract preparation (95165). In 2026, 1 unit is strictly defined as 10ml of extract. If the clinical log shows 12ml but you bill for 1 unit, you lose revenue. If you bill for 2 units without a 20ml log, you trigger an audit. We implement Revenue Integrity protocols to ensure that your preparation math is perfectly synchronized for 100% initial payment success.
Billing for venom immunotherapy (95144–95149) requires absolute precision in documenting the "Number of Venom-Doses" per vial. In 2026, most generalist billers lose 6-10% of their venom revenue simply by failing to capture the separately identifiable complexity of multi-venom treatments and the technical-modifier requirements. MDRG’s Revenue Cycle Management experts specialize in "Dose-Sync" auditing to maximize your technical yield.
Payers have implemented aggressive "Prior Auth" hurdles for high-cost biologics used in asthma and chronic urticaria. Most practices lose significant procedural revenue simply by failing to satisfy the specific "Clinical-Outcome" criteria required for authorization *before* the drug reaches the clinic.
Topical authority in allergy and immunology RCM involves mastering the 95000-series CPT codes and the nuances of high-complexity immune system diagnostics. Our allergy-certified coders ensure every Revenue Cycle Management submission is optimized for 2026 technical success.
Antigen-count documentation parity
Unit-level & venom-dose precision
Professional time-capture logic
MDM complexity for chronic immune disease
Sequential time-based documentation
Technical vs. Professional splits
Defending evaluation parity
In 2026, allergy billing is a battle of "Measurement Precision." Payers are no longer just looking for coding errors; they are using AI-driven auditing to challenge the *units* and *antigen counts* of your diagnostics. We defend your revenue against these three high-frequency rejection types:
Payer bots often deny extract preparation claims if they detect a "Volume-Log Discrepancy"—where the number of antigens billed doesn't align with the vial size documented. In 2026, this is the #1 reason for lost revenue in high-volume allergy groups.
For ingestion challenge testing (95076), payers often trigger technical denials if the note doesn't explicitly list the *exact start and end times* for the initial 120 minutes. If the log is general, the payer will downcode the entire procedure.
For newer specialized immune-pairings or advanced biologic transitions, payers often trigger "Experimental" denials even for FDA-cleared hardware.
In 2026, the key to allergy revenue is the "Diagnostic Intensity Narrative." We help your providers implement "Audit-Armor" charting strategies that signal authority to payer algorithms. This includes using "Trigger Phrases" for visit necessity and automating the capture of specialized test technical data.
We help you structure your skin-test summaries so that the "Technical Necessity" of a separately identifiable encounter is undeniable to even the most aggressive automated payer bots.
We teach your team how to describe sequential ingestion testing in a way that reflects the true "Sequential Intensity" of the Care, maximizing your per-challenge professional yield.
MDRG acts as your practice’s "Immunological RCM Command Center." We focus entirely on Revenue Cycle Management efficiency so you can focus on clinical diagnostics and patient care.
We synchronize with your allergy-specialized EHR (Mod-Med/EMA, Athena, eCW, NextGen, etc.) to establish a clean, high-speed data bridge.
Every allergy claim is scrubbed for 2026 CPT/Diagnosis parity before it hits the clearinghouse. We look for "Unit-Mismatch Red-Flags" that AI-payers use to auto-reject high-value extract lines.
We don't accept "No." We challenge every technical surgical and diagnostic denial with clinical precision, leveraging our certified coders to file high-level appeals for your most complex cases.
Track your net collections, "Per-Antigen Yield," and payer performance points with total transparency via our secure client portal.
To defend your immunological revenue in 2026, your diagnostic and extract records must be bulletproof. We provide our allergy clients with a rigorous documentation checklist to ensure compliance:
In a technical audit for a 6-physician independent allergy group in the Northeast, MDRG identified a $182,000 annual revenue leakage in their Immunotherapy Extraction and Skin Testing billing. The group was failing to correctly document "Volume-Based Unit Math" and was losing the technical value of their separately identifiable E/M visits.
By implementing Revenue Cycle Management best practices—including real-time "Unit-Capture Training" for their clinical staff—MDRG was able to: * **Recover $118,000 in uncaptured extract and diagnostic revenue** within the first 6 months. * **Reduce their "Unit-Mismatch" Denial Rate** by 64% using specialized technical narratives. * **Accelerate Cash Flow** by reducing their average days in A/R from 45 days to 23 days.
This immunologist group now operates with "Audit-Armor" protection, knowing that every high-volume patient hour is protected from automated payer clawbacks.
In the high-volume environment of 2026, your allergy practice deserves a revenue cycle that is as precise as your clinical care. Don't let your "Immunological Value" be eroded by primitive billing and administrative friction.
Direct PDF download. We respect medical practice privacy.
Get a free audit of your billing. If we don't find money you're leaving on the table, you don't pay a dime.